Abstract MHC-linked genes strongly influence susceptibility to autoimmune diseases and also regulate responses to exogenous antigens. To begin to understand the mechanism of this MHC effect on disease, we have investigated MHC-congenic mouse strains that develop spontaneous autoimmunity because of the Ipr gene. C57BL6/lpr (B6/lpr) mice (H-2b) are known to have substantial levels of autoantibodies to chromatin, single stranded DNA (ssDNA3), and IgG of different murine subclasses (rheumatoid factor). We have crossed the H-2d and the H-2bil2 (la mutant) haplotypes onto the B6/lpr background. Surprisingly, levels of all of the autoantibodies were markedly lower in B6/lpr.H-2d, but levels in B6/lpr.H-2b l2 were no different from those in B6 /lpr mice. The downregulating influence of the H-2d allele was dominant, and there was no effect on autoantibody fine specificities. The genetics of the H-2d effect and its diffuse influence on multiple autoantibody specificities, in addition to the lack of effect of the bml2 mutation, which modifies the peptide-binding groove of I-A, together raise the question of whether MHC-linked genes other than classical (IR) genes may be responsible for MHC disease associations in this model. (J. Clin. Invest. 1993. 91:2761-2768.) Key words: systemic lupus erythematosus -autoantibody -major histocompatibility complex -murine models * immune response genes
ssDNA, respectively) ', and to a shortened lifespan due to glomerulonephritis (6) . In addition, the autoimmune disease of the BXSB mouse is less severe in animals expressing H-2d instead of the H-2b allele normally present in this strain (7) .
The autosomal recessive lpr gene, recently demonstrated to be a nonexpressed mutant form ofthe Fas apoptosis-inducing cell surface receptor (8) , causes lymphadenopathy and autoantibody formation. The nature and severity ofdisease are dependent on background genes (9) , and lpr accelerates any underlying autoimmune proclivity. For example, MRL/Mp-lpr/lpr mice develop massive lymphadenopathy; antibodies to multiple autoantigens including dsDNA, ssDNA, chromatin, IgG, Su, ribosomal P protein, and Sm, as well as severe renal disease. In contrast, C57BL/6-lpr/lpr (B6/lpr) mice develop more modest lymphadenopathy and antibodies to chromatin, ssDNA, and IgG (9) , but fail to develop antibodies to Sm or dsDNA, and do not have vasculitis or renal disease. Intercross analysis has shown that multiple background genes are responsible for the differences in the lpr-induced autoimmunity, and it has thus far not been possible to demonstrate an MHC effect on renal disease or autoantibody production (10) . We have, therefore, sought a system free ofthe influence of other genetic differences to study the effects ofMHC genes on systemic autoimmunity. We thus took advantage of the existence of H-2 congenic C57BL/6 strains to derive new lpr strains that differ only at MHC loci. The results indicated that substitution ofthe H-2d allele for H-2b resulted in diminished autoimmunity, but that H-2bml2 did not influence autoantibody production. Surprisingly, the reduction in autoimmunity observed in B6/lpr-H-2d reflected a generalized lowering of autoantibody production rather than an effect on autoantibody fine specificity.
Methods
Mice. C57BL/6 (B6) and C57BL/6-lpr/lpr (B6/lpr) mice (H-2b); and HWl9 (H-2d-congenic B6) mice were originally obtained from the Jackson Laboratory (Bar Harbor, ME) and maintained in our breeding colony at the University of North Carolina at Chapel Hill. B6.C-H-2bml2 (bm12) mice were originally obtained from Dr. Roger Melvold, Northwestern University (Evanston, IL) and have been bred in our colony.
To produce H-2d-congenic B6/lpr mice, we crossed B6/lpr and HW19. Fl hybrid mice were intercrossed, and the F2 generation was screened for lpr homozygosity by assessing antichromatin autoantibodies and rheumatoid factors by ELISA. H-2 phenotype was determined by immunofluorescence using AF6-88.5.3 (anti-H-2Kb) and SFl-1.1.I (anti-H-2Kd), both from American Type Culture Collection, (Rock-ville, MD). To obtain H-2d homozygous founder mice, it was necessary to intercross one more generation. The B6/lpr.H-2d mice were also crossed to B6 /lpr, and the F2 generation was tested for segregation of H-2 phenotype and autoantibody levels (see text).
To produce the B6 /lpr.H-2bmI2 strain, B6 /lpr was mated to bm 12, and F2 mice screened in a fashion analogous to that described above. Typing for I-Ab was accomplished by immunofluorescence using D3137.5 (anti-I-Ab); as there is no I-Abm12-specific reagent generally available, bm 12 mice were identified by their lack of lab. Additional intercrosses were necessary to generate B6/lpr.H-2bmI2 homozygous founder mice. The identity of B6/lpr.IH-2lbml2 mice was also confirmed by their characteristic response to immunization with insulin ( 11) .
IgG antichromatin. Chromatin Ag was purified from chicken erythrocyte nuclei ( 12) . Polyvinyl chloride microtiter plates (Dynatech Laboratories, Inc., Chantilly, VA) were coated with 100 pJ of a 3-Mg/ml chromatin solution in borate-buffered saline (BBS), pH 8.4, for 5 h at 4°C. After washing with BBS and incubating with 200 ,l of coating buffer (BBS, 0.5% BSA, 0.4% Tween 80) for 1 h at 4°C, serum samples (diluted 1/500 in coating buffer) were added. After overnight incubation at 4°C, the plates were washed five times with BBS, and a 1/2,000 dilution of biotinylated affinity-purified goat anti-mouse IgG (pFc' specific) was added for 1 h at 4°C. After washing, the plates were incubated with avidin-alkaline phosphatase (Zymed Labs, Inc., South San Francisco, CA) for 1 h at 4°C. After further washing, phosphatase substrate (Sigma Chemical Co., St. Louis, MO) was added in 0.01 M diethanolamine, pH 9.8, to each well. The plates were read with an automated micro-ELISA reader at 1, 3, and 24 h after substrate addition. A standard curve was constructed using a high titer MRL/lpr mouse serum, and EDF (equivalent dilution factor) values were calculated according to the following formula: EDF = (dilution of standard reference sera that gives the equivalent OD of the test serum) x 106. The standard dilution curves were usually linear and not steep in the OD range tested.
Anti-ssDNA. Calf thymus DNA (Sigma Diagnostics Co, St. Louis, MO) was denatured at 100°C for 10 min, and 100 ML of a 10-,ug/ml solution of ssDNA was added to each well. The antibodies were detected with a biotinylated affinity-purified rat anti-mouse K monoclonal antibody. A high titer MRL/lpr mouse serum was used for the standard curve.
Anti-dsDNA. The indirect fluorescent antibody procedure for the detection of anti-dsDNA antibodies was performed with substrate slides of Crithidia luciliae (Kallestad Diagnostics, Inc., Chaska, MN). The serum samples diluted 1 / 10 were incubated 30 min in a moist box. After washing with PBS, anti-dsDNA antibodies bound to the Crithidia kinetoplast DNA were detected with a rabbit anti-mouse IgG linked to a fluorochrome (FITC). 30 min later, the slides were read using a fluorescence microscope at a magnification of 400. An anti-dsDNA positive MRL/lpr hybridoma and an anti-dsDNA negative tissue culture supernatant were used as controls.
Rheumatoid factors and total IgM. Rheumatoid factor and total serum IgM were tested in assays similar to those described above. The plates were coated with monoclonal reagents rendered free of IgM by previous absorption. Myeloma proteins used as antigen for detection of isotype specific rheumatoid factors were as listed in ( 13) except for IgGla (HB57) and the IgG2aa (P1.17). Antibodies to these platebound IgGs were detected with biotinylated affinity-purified Bet-2 rat anti-mouse IgM F(ab')2, followed by avidin-alkaline phosphatase and substrate.
Immunizations. Mice were given 50 ,g of human gamma globulin (HGG) purified from Cohn Fraction II of human serum or keyhole limpet hemocyanin (KLH) (Sigma Chemical Co.) subcutaneously in CFA. They were boosted with 50 ,tg of antigen in incomplete Freund's adjuvant 10 The electrophoresis was performed at 20 mA for 2.5 h. The separated polypeptides were transferred to nitrocellulose paper by electroblotting in transfer buffer (25 mM Tris hydroxide, 192 mM glycine, 20% methanol) at 100 V for 45 min on ice. Nitrocellulose paper was then cut into strips and pressed overnight. The next day, the strips were incubated with Tris-buffered saline 5% milk for 1 h. After washing, the serum samples, diluted 3 Ml/ml in TBS, were added. After overnight incubation, the antibodies were detected with biotinylated affinity-purified rat anti-mouse K diluted 1/ 1,000, followed by avidin-alkaline phosphatase. Antibody binding was visualized using nitroblue tetrazoliumbromo-chloro-indolyl phosphate, Sigma Chemical Co.
Measurement ofproteinuria. Protein was estimated in spot urines from F2 mice (Albustix; Miles Inc., Elkhart, IN). Protein concentration in the urine was classified according to five categories (0-4+).
Results
Antichromatin in MHCcongenic lpr mice. Antichromatin antibodies were quantitated by ELISA in sera from B6/lpr and B6/lpr.H-2d mice at 5 mo ofage. In Fig. 1 a, it can be seen that antichromatin levels in the H-2d mice were lower than those measured in samples from H-2' individuals (P < 0.001 for comparison of pooled male and female samples of each strain by Student's t test). B6/lpr female mice had significantly higher levels of antichromatin than males (P = 0.0001), but there was no sex difference in antichromatin levels for B6/ lpr.H-2d (P = 0.8).
To ensure that the differences observed between the B6 /lpr and B6/lpr.H-2d mice segregated with H-2, we mated B6/lpr and B6/lpr.H-2d mice and intercrossed the Fl offspring. In the F2 generation, there were 28 H-2b/b mice, 43 H-2b/d mice, and 24 H-2d/d mice. As shown in Fig. 1 b, sera from the bb mice contained significantly more antichromatin antibodies than sera from dd individuals (P < 0.001 ). Antichromatin levels in bd mice were not significantly different from those of dd mice (P = 0.71). Immunoblot analysis of antichromatin in lpr strains. The ELISA results thus indicated significant differences between B6/lpr and B6/lpr.H-2d, but not between B6/lpr and B6/ lpr.H-2 ml2. It was possible that the difference observed in the former case was caused by the absence of reactivity to one of the histone components of chromatin, with preservation of reactivity to the remaining histone constituents of this antigen. To approach this question, serum samples from B6/lpr, B6/ lpr.H-2d, and B6/lpr.H-2 bml2 mice with high levels of antichromatin reactivity by ELISA were selected for further analysis by immunoblotting. Western blot results (Fig. 3) Anti-DNA in MHC-congenic lpr mice. As was seen for antichromatin, anti-DNA titers were significantly lower in Ipr mice expressing the d haplotype. This was ascertained by comparing anti-ssDNA levels in a cohort of parental B6/lpr and B6/lpr.H-2d individuals (not shown). The data were confirmed in an analysis of F2 mice (Fig. 4 a) . Those mice which inherited the dd and bd haplotypes had significantly lower levels of anti-DNA than bb individuals (P < 0.05). In contrast to these results, B6/lpr.H-2bml2 mice showed anti-DNA levels that were similar to those of B6/lpr. As seen in Fig. 4 b, although there was a modest decrease in the female B6/lpr.H2bm12 mice, this did not achieve statistical significance. We also measured anti-dsDNA in B6/lpr.H-2d and B6/lpr.H-2bml2. None of these strains showed any positivity in the Crithidia luciliae immunofluorescence assay.
Rheumatoidfactor levels in congenic lpr mice. B6/lpr mice are known to produce substantial amounts of rheumatoid factor ( 14) . We determined the effect ofMHC haplotype substitutions on the amount and specificity of this autoantibody. Rheumatoid factor in parental B6/lpr mice was present in significantly higher levels than in B6/lpr.H-2d animals (data not shown). As was done for the other autoantibody measurements, results were confirmed in F2 mice. Fig. 5 a shows that IgM anti-IgG 1b levels were markedly lower in bd and dd mice. The same was true for anti-IgG2bb (Fig. 5 b) . Levels in bd mice were not significantly different from those measured in dd animals. In contrast to these data, there was no difference between 2764 Cohen et al. B6/lpr and B6/lpr.H-2bml2 rheumatoid factor titers against the IgGIb and IgG2b isotypes (Fig. 6) . In an effort to discern differences in rheumatoid factor fine specificity between B6/lpr and B6/lpr.H-2bml2, we measured IgM antibody against both a and b allotype myeloma proteins representing all ofthe murine subclasses (Fig. 6 ). There were no differences between the two strains.
Responsiveness of congenic lpr mice to immunization. It was possible that the lower autoantibody levels in B6/lpr.H-2d mice reflect a generalized decreased responsiveness to antigenic stimulation. This question was approached by assessing antibody responses to HGG and KLH. As seen in Table I , there was no difference between B6/lpr and B6/lpr.H-2d mice in antibody levels after immunization.
Other studies in MHC-congenic lpr strains. We compared the total spleen and lymph node weights of 7-mo-old MHCcongenic lpr mice (Table II) Figure 5 . Isotype-specific rheumatoid factors directed against IgGl b (a) and IgG2bb (b) in F2(bb), F2(bd), and F2(dd) mice. H-2b homozygous mice were significantly different from B6/lpr-H-2d and from F2 (bd) for both specificities (P < 0.001). ., females; ., males.
were significantly greater in the bd mice (P = 0.04), yet spleen weights were not significantly different (P = 0. 14). We also tested for proteinuria in female mice of these strains using the semiquantitative Albustix method and found 16 
Discussion
We have created two congenic B6/lpr mouse strains: B6/ lpr.H-2d, which expresses the d allele of the H-2 complex in place of the b allele expressed by B6/lpr; and B6/lpr.H-2bml2, which is identical to B6 /lpr, except that it expresses the bm 12 mutation at I-A13. B6/lpr.H-2d mice had substantially lower levels of spontaneous autoantibodies to chromatin, single stranded DNA, and mouse IgG. In contrast, B6/lpr.H-2bml2 mice were identical to B6/lpr mice in these assays. The present data are consistent with earlier reports in the NZB/NZW and NZB/SWR models implicating an MHC gene effect on systemic autoimmunity (5, 15) . The results differ, however, from findings of an exacerbating effect of the bm 12 I-A phenotype on NZB autoimmune disease (6) . It has been suggested that the acceleration ofautoimmunity imposed by the bm 12 haplotype may be caused by an amino acid substitution at position 72 of I-A#3, a position also implicated as the possible locus of the NZW contribution to the autoimmunity of NZB/NZW (6). The present results indicate that the bm 12 effect on NZB is not generalizable to all strains. Our data also differ in that the NZB (H-2d) and NZB.H-2b showed similar levels of autoantibodies. The differences between our findings and the effects ofdifferent H-2 haplotypes on NZB are likely to be caused by the many genetic differences between NZB and the B6/lpr model, for instance at the level of T cell receptor repertoire. H-2 haplotype has recently been shown to affect the systemic autoimmune disease of BXSB mice (7). The substitution of H-2d for the H-2" haplotype led to decreased autoantibody production, diminished glomerulonephritis, and enhanced survival. These results are analogous to ours, and may reflect the similarities in background genes between B6 and the related BXSB strain.
It is possible that the observed differences in autoantibody production by lpr strains with different MHC haplotypes are caused by the allelic differences in class II MHC gene function, analogous to the classic experiments demonstrating Ta control of the response to exogenous antigens. This interpretation would fit well into current paradigms of immunology. Like exogenous antigens, autoantigens could be regarded as polypeptides that undergo processing and ultimately bind to surface class II MHC antigens for presentation to T cells. In fact, in the immune response (IR) gene literature, there is precedent for immune responses to modified selfantigens such as albumin or IgA under such MHC-linked gene control ( 16) . Allelic Ta polymorphisms might thus reflect the different efficiencies with which certain Ia antigens bind peptides processed from particular autoantigens. The molecular basis of this phenomenon is widely believed to be the three-dimensional structure of an antigen-binding groove demonstrated on the exterior of MHC molecules. It is also possible that the MHC-determined differences in autoantibody production reflect differences in the T cell repertoire that develops in the presence of the MHC b haplotype versus the d haplotype, or that the MHC differences result in altered immune response because of suppressor cell activity. Both of these latter mechanisms have been proposed as explanations of classic MHC-linked IR gene phenomena ( 17 ) . The greater lymph node and spleen size of the b haplotype mice, compared to the d haplotype individuals, might reflect a more intense T cell immune response in the former, with consequent generation of increased numbers of double negative cells, or might be caused by interstrain differences in T cell repertoire.
The observations concerning the d haplotype might alternatively be explained by the expression in this haplotype of I-E molecules, which are not expressed in B6/lpr or B6/lpr.H2bm12 because ofthe nonfunctional Ea gene ofthe b haplotype. Such a mechanism would imply a suppressive effect of I-E expression on autoimmunity, similar to the effect of I-E on autoimmune diabetes in the non-obese diabetic model (18, 19) , and on mercuric chloride-induced antinucleolar antibodies (20) . A potential finding of importance to these studies is the recent observation that I-E-derived peptides may be detected bound to purified I-A molecules (21 ) . Mice expressing I-E may thus generate peptides that bind to their surface I-A and undermine its capacity to bind other peptides, perhaps reducing immune responses. Any suppressive effect of I-E, while of potential importance in the preceding models, clearly would not be sufficient to alleviate systemic autoimmune disease in all cases, as severe autoimmunity is seen in the I-E+ (NZB x NZW) and (NZB X SWR) Fl mice, as well as in MRL/lpr.
Nevertheless, I-E expression may well have important influences on the nature of autoimmunity by shaping of the T cell repertoire or providing suppressive signals. In the BXSB model, it was ofinterest that the expression ofI-E in H-2d mice led, as expected, to the deletion of T cells expressing V#5 and V#I 1 (7) . Nevertheless, it appeared unlikely that the loss of these T cells was responsible for the ameliorating effect of H-2 d, because H-2bid mice developed a syndrome resembling that of H-2b mice, despite the reduction in VI35-and Vf I1-bearing T cells. These results also argued against a generalized protective effect of I-E expression in that system. We are currently exploring the influence of I-E in our model by examining other MHC-congenic B6/lpr mice that express I-E, and by assessing autoimmunity in I-E. transgenic lpr mice.
Our data show that female individuals, particularly B6/lpr mice, produce larger amounts of autoantibodies than males. This observation is consistent with heightened systemic autoimmunity observed in females. It is possible that the increased levels of autoantibodies in the females are related to increased numbers ofautoreactive T cells, particularly in the H-2" strain. In females, estrogens may favor extrathymic differentiation in the liver of T cells with autoreactive characteristics, and thus may lead to enhanced production of autoantibodies (22).
Another interesting aspect of our data is the lack of influence of the bm 12 mutation on autoantibody levels. Although only three residues in I-AI3 differ between H-2b"l2 and H-2", these two alleles are generally associated with major differences in immune responsiveness to foreign antigens ( 11 ) and in susceptibility to experimental myasthenia gravis (23) , probably because the altered amino acid residues lie within the peptide binding groove of the I-A(3 chain. In addition, as discussed previously, NZB.Iml2 mice have considerably higher titers of autoantibodies than NZB.H-2" mice (6) (24) . IR gene polymorphisms would not be expected to result in apparently global changes in spontaneous autoantibody production we have observed in our H-2 congenic lpr mice, but rather in changes in the fine specificity of certain autoantibodies, with perhaps increases in some specificities, along with decreases in others. We thus suggest that other genes in the MHC complex may affect the lpr syndrome. Known genes include class I antigens, which are surface glycoproteins involved in peptide antigen binding and interaction with CD8 + T cells; tumor necrosis factors a and f3, which have been reported to have a potent influence on autoimmune and inflammatory phenomena (25) ; C2 and C4 genes, also linked to disease susceptibility (2); the HSP 70 heat shock protein gene (26); a series ofsingle copy genes of uncertain function (27) ; and an array of highly interesting recently discovered class II-linked genes that are responsible for the intracellular transport ofpeptides and for the degradation of protein antigens into small peptides for binding to class I and class II molecules (28) . It is possible that the suppressive effect on autoantibodies resulting from the substitution of the d for the b MHC allele might involve any one of these non-Ia genes. For instance, autoantibody formation could be influenced by general differences in autoantigen peptide binding or binding of an autoantigen peptide, which plays a broad role in T-B collaboration; class I mediated suppressive effects; variations in peptide transporter genes or in genes controlling protein degradation (29, 30) ; or effects ofyet-undiscovered genes that may also be encoded in the MHC. Recently, it has been shown that peptide transporter gene polymorphisms may influence the peptides bound by MHC genes (31 ) . Such MHC-linked polymorphisms may prove to have clinical relevance by exerting a broad effect on antigen presentation in autoimmune disease.
